Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04008472
Other study ID # I14036 - GERONTACCESS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2015
Est. completion date May 2019

Study information

Verified date July 2019
Source University Hospital, Limoges
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For several decades, there is an aging population, particularly in industrialized countries. This lengthening of the duration of life is accompanied by an increase in the number of chronically ill patients. On an estimate of 15 million patients in France today, the figure reported for 2020 would be 20 million patients. Chronic diseases are responsible for functional decompensation and admission responsible autonomy breaks in nursing homes (Accommodation Establishment of People Dependent Elderly).

An estimated 700,000 the number of people currently living in retirement homes in France. These residents are mostly dependent and multiple pathologies requiring regular general and specialist medical monitoring . Medical concern demographic outlook and the need for access to quality care across the country leads to the development of telemedicine.

The need for telemedicine is not the same throughout the territory. It is less, or different, in highly urbanized areas where the density of health professionals is high, then it can be a new response to the needs of rural, isolated or landlocked. Telemedicine promotes the development of the concept of graduated care sector, especially in the management of patients with chronic diseases.

Telemedicine in rural nursing homes and can be a tool for assessing, monitoring and coordination to avoid decompensation of chronic conditions and rehospitalization.

This organization can afford to break the isolation of general practitioners and EHPAD coordinators physicians in rural areas and provide access to several specialties.


Recruitment information / eligibility

Status Completed
Enrollment 428
Est. completion date May 2019
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria:

- Resident in one of 9 nursing homes participating in the project

- Resident polypathologique has at least two comorbidities

- Having made no request to change place of residence at the time of the inclusion visit

- Having given free consent, informed writing and signed by himself and / or his legal representative

Exclusion Criteria:

- Unaffiliated resident or non-receiving of social security

- severe pathology (ies) involving life-threatening in the short term

- Resident whose return home, transfer to another nursing home or to a long term care unit is programmed

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Telemedecine
Initiation of tele-medical consultation with the resident, a caregiver for the nursing home, the referring physician and geriatrician téléexpert. After a overall geriatric assessment in nursing homes by UPSAV the first teleconsultation is organized within 10 days. Subsequent visits are scheduled every 3 months for 12 months. Spontaneous visits can be requested at the initiative of the referring physician.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Limoges

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of telemedicine on prevention in old and polypathological patients Proportion of patients with emergency admission or unscheduled hospitalization in medical or surgical service over 12 months. After 12 months
Secondary Medico-economic impact cost effectiveness of the telemedicine device After 12 months
Secondary Impact on recurring hospitalizations Number of readmissions After 12 months
Secondary Impact on overall health Number of emergency admissions Number of readmissions Number of days of hospitalization Number of medical consultations o After 12 months
Secondary Impact on the quality of life ( EQ5D questionnary) The EQ-5D (Europen Qyuality of llive) five dimension scale) questionnaire has two components: health state description and evaluation.
In the description part, health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Mobility dimension asks about the person's walking ability. Self-care dimension asks about the ability to wash or dress by oneself, and usual activities dimension measures performance in "work, study, housework, family or leisure activities". In pain/discomfort dimension, it asks how much pain or discomfort they have, and in anxiety/depression dimension, it asks how anxious or depressed they are.
Higher values represent a worse outcome.
The scale ranges from 5 to 15.
After 12 months
Secondary Impact on mortality Proportion of patients who died at 12 months After 12 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06016101 - Usefulness of the Medissimo Nurse Application for Supporting Medication Compliance in Elderly People With Chronic Polypathologies
Completed NCT02809417 - Interest of the Use of the Web Platform LICORNE (LIaison and COoRdination With a NumériquE Health Reseau) Concerning Coordination of Care for Dependant Elderly Patients N/A